Πέμπτη 16 Μαρτίου 2017

Haematological cancer: Treg predict responsiveness to blinatumomab.

Related Articles

Haematological cancer: Treg predict responsiveness to blinatumomab.

Nat Rev Clin Oncol. 2017 Mar 14;:

Authors: Sidaway P

PMID: 28290492 [PubMed - as supplied by publisher]



http://ift.tt/2mvAvWE

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου